Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
267,345,021
-
Share change
-
-6,083,666
-
Total reported value
-
$9,516,157,881
-
Put/Call ratio
-
51%
-
Price per share
-
$35.58
-
Number of holders
-
780
-
Value change
-
-$214,572,222
-
Number of buys
-
404
-
Number of sells
-
275
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q1 2023
As of 31 Mar 2023,
GSK plc - SPONSORED ADR (GSK) was held by
780 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
267,345,021 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, JTC Employer Solutions Trustee Ltd, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, PRIMECAP MANAGEMENT CO/CA/, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and MORGAN STANLEY.
This page lists
792
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.